Perilla frutescens: A traditional medicine and food homologous plant

IF 4.7 4区医学 Q1 CHEMISTRY, MEDICINAL

Chinese Herbal Medicines Pub Date : 2023-07-01 DOI:10.1016/j.chmed.2023.03.002

Xinling Wu , Shuting Dong , Hongyu Chen , Miaoxian Guo , Zhiying Sun , Hongmei Luo

引用次数: 2

Abstract

Perilla frutescens, an annual herb of the Labiatae family, has been cultivated in China for more than 2000 years. P. frutescens is the one of the first medicinal and edible plant published by the Ministry of Health. Its leaves, stems and seeds can be used as medicine and edible food. Because of the abundant nutrients and bioactive components in this plant, P. frutescens has been studied extensively in medicine, food, health care and chemical fields with great prospects for development. This paper reviews the cultivation history, chemical compositions and pharmacological activities of P. frutescens, which provides a reference for the development and utilization of P. frutescens resources.

查看原文本刊更多论文

紫苏:一种传统的药用和食用同源植物

紫苏是唇形科的一年生草本植物，在中国已有2000多年的栽培历史。frutescens是卫生部公布的首批药用和食用植物之一。它的叶、茎和种子可药用和食用。由于其丰富的营养成分和生物活性成分，frutescens在医学、食品、保健和化学等领域得到了广泛的研究，具有广阔的发展前景。本文综述了紫苏的栽培历史、化学成分和药理活性，为紫苏资源的开发利用提供参考。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chinese Herbal Medicines CHEMISTRY, MEDICINAL-

CiteScore

4.40

自引率

5.30%

发文量

629

审稿时长

10 weeks

期刊介绍： Chinese Herbal Medicines is intended to disseminate the latest developments and research progress in traditional and herbal medical sciences to researchers, practitioners, academics and administrators worldwide in the field of traditional and herbal medicines. The journal's international coverage ensures that research and progress from all regions of the world are widely included. CHM is a core journal of Chinese science and technology. The journal entered into the ESCI database in 2017, and then was included in PMC, Scopus and other important international search systems. In 2019, CHM was successfully selected for the “China Science and Technology Journal Excellence Action Plan” project, which has markedly improved its international influence and industry popularity. CHM obtained the first impact factor of 3.8 in Journal Citation Reports (JCR) in 2023.